- Home
- RVSB vs ATOS Comparison
RVSB vs ATOS Comparison
Compare RVSB & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- ATOS
- Stock Information
- Founded
- RVSB 1923
- ATOS 2009
- Country
- RVSB United States
- ATOS United States
- Employees
- RVSB N/A
- ATOS N/A
- Industry
- RVSB Savings Institutions
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- ATOS Health Care
- Exchange
- RVSB Nasdaq
- ATOS Nasdaq
- Market Cap
- RVSB 107.6M
- ATOS 107.2M
- IPO Year
- RVSB 1993
- ATOS 2012
- Fundamental
- Price
- RVSB $4.86
- ATOS $0.81
- Analyst Decision
- RVSB Buy
- ATOS Strong Buy
- Analyst Count
- RVSB 1
- ATOS 3
- Target Price
- RVSB $7.00
- ATOS $6.17
- AVG Volume (30 Days)
- RVSB 39.2K
- ATOS 470.8K
- Earning Date
- RVSB 10-23-2025
- ATOS 11-11-2025
- Dividend Yield
- RVSB 1.62%
- ATOS N/A
- EPS Growth
- RVSB 163.90
- ATOS N/A
- EPS
- RVSB 0.24
- ATOS N/A
- Revenue
- RVSB $51,318,000.00
- ATOS N/A
- Revenue This Year
- RVSB $11.67
- ATOS N/A
- Revenue Next Year
- RVSB $12.55
- ATOS N/A
- P/E Ratio
- RVSB $20.56
- ATOS N/A
- Revenue Growth
- RVSB 9.48
- ATOS N/A
- 52 Week Low
- RVSB $4.45
- ATOS $0.55
- 52 Week High
- RVSB $6.59
- ATOS $1.66
- Technical
- Relative Strength Index (RSI)
- RVSB 42.63
- ATOS 53.12
- Support Level
- RVSB $4.83
- ATOS $0.81
- Resistance Level
- RVSB $5.12
- ATOS $0.85
- Average True Range (ATR)
- RVSB 0.14
- ATOS 0.03
- MACD
- RVSB -0.00
- ATOS 0.01
- Stochastic Oscillator
- RVSB 26.67
- ATOS 60.80
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.